Penn. paying for counter-detailing
“If you just practice smart, you'll be able to give better care and, by the way, save money,” Avorn said. He first developed an academic detailing program 25 years ago while in medical school.
It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.
Two FDA guidance documents aim to help pharma companies show the value of their drugs to payers beyond what's included in FDA labeling.
For the first time, the nonprofit is trying to eliminate bans on gay and bisexual men donating blood in countries other than the U.S.